ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 64 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,768,284 | -73.3% | 333,010 | -52.0% | 0.00% | -100.0% |
| Q2 2023 | $6,616,880 | +143.6% | 694,321 | +181.1% | 0.00% | 0.0% |
| Q1 2023 | $2,716,736 | -34.4% | 246,976 | -11.7% | 0.00% | 0.0% |
| Q4 2022 | $4,139,042 | +18.2% | 279,665 | +52.6% | 0.00% | 0.0% |
| Q3 2022 | $3,503,000 | +70.9% | 183,297 | +90.6% | 0.00% | – |
| Q2 2022 | $2,050,000 | +70.1% | 96,178 | +53.7% | 0.00% | – |
| Q1 2022 | $1,205,000 | +20.5% | 62,573 | +29.7% | 0.00% | – |
| Q4 2021 | $1,000,000 | +3.0% | 48,234 | +18.7% | 0.00% | – |
| Q3 2021 | $971,000 | +12.1% | 40,627 | +27.9% | 0.00% | – |
| Q2 2021 | $866,000 | +39.9% | 31,759 | +48.4% | 0.00% | – |
| Q1 2021 | $619,000 | -90.2% | 21,397 | -90.5% | 0.00% | -100.0% |
| Q4 2020 | $6,322,000 | +20.3% | 224,765 | +25.3% | 0.00% | +100.0% |
| Q3 2020 | $5,256,000 | +1.1% | 179,376 | +4.3% | 0.00% | -50.0% |
| Q2 2020 | $5,199,000 | -12.6% | 171,914 | -13.9% | 0.00% | 0.0% |
| Q1 2020 | $5,949,000 | – | 199,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |